News.
Stay up to date with the latest news about our innovation initiatives
Published on 20/09/2023
New AlmirallShare call coming soon
We are looking for collaboration opportunites focused on pathological mechanisms common across different organs and tissues that can be translatable to skin diseases
AlmirallShare new call is seeking new partenship opportunities for preclinical and clinical stage assets that can become new treatments for skin diseases
Almirall and Inserm Transfert enter into a licensing and research collaboration to develop innovative treatments for vitiligo
Almirall announces a collaboration with the University of Michigan to gain understanding of disease drivers in hidradenitis suppurativa
Almirall and IRB Barcelona announce a research collaboration to discover novel molecular glue therapeutics for severe skin diseases
